Full Text View
Tabular View
No Study Results Posted
Related Studies
IL1-TRAP, Rilonacept, in Systemic Sclerosis
This study is currently recruiting participants.
Verified July 2012 by Boston University
Study NCT01538719   Information provided by Boston University

First Received on February 21, 2012.   Last Updated on July 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Scleroderma
Systemic Sclerosis
Diffuse Scleroderma
Diffuse Systemic Sclerosis
Additional conditions recognized in this trial
Scleroderma, Diffuse
Scleroderma, Localized
Scleroderma, Systemic
Sclerosis
More general conditions related to this trial
Connective Tissue Diseases
Pathologic Processes
Skin Diseases
Interventions listed in this trial
Rilonacept
Placebo
Sponsors listed in this trial
Boston University
Regeneron Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services